TITLE

January and you still have head lice!

AUTHOR(S)
Burnside, Mimi
PUB. DATE
January 2015
SOURCE
Clinical Advisor;Jan2015, Vol. 18 Issue 1, p98
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
100943716

 

Related Articles

  • No-Nit Policy No Good?  // Scholastic Parent & Child;Feb/Mar2003, Vol. 10 Issue 4, p65 

    Focuses on lice infestation among the U.S. school children. Estimation of head lice in the year 2003 by the American Academy of Pediatrics (AAP); Objection made by the AAP on the no-nit policy.

  • Formulary Drug Reviews - Spinosad 0.9% Topical Suspension. Cada, Dennis J.; Levien, Terri L.; Baker, Danial E. // Hospital Pharmacy;Jun2011, Vol. 46 Issue 6, p436 

    The article offers information on Spinosad 0.9% topical suspension, a topical head lice infestation treatment. It states that spinosad is made from fermented Saccharopolyspora spinosa, an actinomycetes bacterium derived from soil, and does not involve any extensive management program for lice....

  • FDA actions.  // Clinical Cardiology Alert;Apr2011 Pharmacology, p2 

    The articles offers news briefs related to the U.S. Food and Drug Administration (FDA). A warning has been issued concerning the use of terbutaline for prevention or prolonged treatment of preterm labor in pregnant women. The FDA has approved Spinosad, a treatment for head lice. A warning...

  • Intrathecal baclofen pump - a viable therapeutic option in pregnancy. Tandon, Saira S.; Hoskins, Iffath; Azhar, Salman // Obstetric Medicine (1753-495X);Sep2010, Vol. 3 Issue 3, p119 

    Baclofen, a gamma-aminobutyric acid analogue, is used as a muscle relaxant and antispasmodic to relieve symptoms in patients with intractable spasticity arising from cerebral or spinal aetiology such as in traumatic brain injury or multiple sclerosis. As it is often used in women of reproductive...

  • Head Lice--New Options For Treatment.  // Child Health Alert;Oct2009, Vol. 27, p3 

    The article presents new treatment options for head lice in children. The U.S. Food and Drug Administration has approved a new head lice treatment product called Ulefia which consists of 5 per cent benzyl alcohol lotion which is safe for children as young as 6 months old. The product works by...

  • Guideline on Xylitol Use in Caries Prevention.  // Pediatric Dentistry;2012 Reference Manual, Vol. 34 Issue 6, p166 

    The article presents a guideline on the use of Xylitol in caries prevention from the American Academy of Pediatric Dentistry (AAPD). According to the guideline, which was adopted in 2011, the sugar polyol Xylitol has been approved by the U.S. Food and Drug Administration as a food additive and...

  • Is there much risk in using fluoroquinolones in children? Hernandez, Rick; Edgerton, Lisa; Flake, Donna // Journal of Family Practice;Aug2008, Vol. 57 Issue 8, p539 

    The article reports that the U.S. Food and Drug Administration (FDA) has warned regarding the increased risk of tendonitis and tendon rupture with fluoroquinolone use in children. Based on clinical studies, the fluoroquinolone use in children has not been associated with tendonopathy but it...

  • Drugs in the News.  // Clarendon Enterprise (TX);5/14/2009, Vol. 20 Issue 20, p5 

    The article offers information on a drug for head lice which was approved by the U.S. Food and Drug Administration.

  • New option available for treating head lice.  // Infectious Diseases in Children;Aug2009, Vol. 22 Issue 8, p46 

    The article reports on the approval by the U.S. Food and Drug Administration on Ulesfia 5% benzyl alcohol lotion as the first non-neurotoxic topical head lice prescription treatment for use in children aged 6 months and older.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics